MIRA INFORM REPORT

 

 

Report Date :

08.02.2014

 

IDENTIFICATION DETAILS

 

Name :

VARDHMAN HEALTH SPECIALITIES PRIVATE LIMITED (w.e.f. 06.07.1998)

 

 

Formerly Known As :

RANAKPUR PHARMA PRIVATE LIMITED

 

 

Registered Office :

No.199/ 5, (New 912), 7th Main, 2nd Block, Jayanagar, Bangalore – 560 011, Karnataka

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

21.03.1997

 

 

Com. Reg. No.:

08-022000

 

 

Capital Investment / Paid-up Capital :

Rs.55.500 Millions

 

 

CIN No.:

[Company Identification No.]

U85110KA1997PTC022000

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BLRV00977E

 

 

PAN No.:

[Permanent Account No.]

AABCV0550E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Distributor of Speciality Drugs.

 

 

No. of Employees :

180 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (43)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 720000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

There appears dip in profitability of the company during the financial year 2013.

 

However, general financial position of the company seems to be sound and healthy.

 

Trade relations are fair. Business is active. Payment terms are reported to be slow but correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

The services sector, the largest contributor to India’s GDP, contracted for the sixth consecutive month in December, as orders dipped. However, hiring has risen.  Direct tax collections rose 12.3 % during the April – December period of the current financial year.  The government has decided to retain 100 per cent foreign direct investment in both greenfield (new) and brown field (existing) pharmaceutical companies, despite concerns over genetic drugs going out of production, if multi-national companies take over domestic ones. In M&A deals, a non compete clause would not be allowed, except in special circumstances. The Department of Industrial Policy and Promotion plans to release the next edition of its consolidated foreign direct investment policy document on March 31, incorporating changes made in the past year. DIPP compiles all policies related to India’s FDI regime into a single document to make it easy for investors to understand. 185 million estimated number of mobile internet users in India by June 2014, according to a report by the Internet & Mobile Association of India and IMRB International.  India had 110 million mobile internet users with 25 million in rural areas. $3.77 tn estimated global IT spending in 2014, according to research firm Gartner Inc. The growth forecast for this year is cut to 3.1 %from the earlier estimate of 3.5 %. The spending growth forecast for telecom services – a segment that accounts for more than 40 % at total IT spending – from 1.9 per cent to 1.2 per cent is the main reason for this overall IT cut. A Reserve Bank of India committee has recommended setting up a special category of lenders who would cater to small businesses and households, to expand the number of customers with access to banking services. These banks would focus onproviding payment services and deposit products.  Indian banks want the free use of automated teller machines to be capped at five transactions in a month including that of the bank in which the account is active. This follows state government order to banks to install security guards at ATM booths after a woman banker was assaulted in Bangalore. The government is likely to present a vote on Account in mid-February. The annual Economic Survey will be tabled later in Parliament along with the full Budget. A full Budget for 2014/15 is likely to be present in July by the new government formed after the General Election. The government will soon launch an internet spy system, called Netra, to detect malafide messages. Security agency will deploy the system to capture dubious voice traffic on applications such as Skype and Google Talk, as well as tweeters.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Vikram Bhatt

Designation :

Accounts Manager

Contact No.:

91-80-40836666

Date :

07.02.2014

 

 

LOCATIONS

 

Registered Office :

No.199/ 5, (New 912), 7th Main, 2nd Block, Jayanagar, Bangalore – 560 011, Karnataka, India

Tel. No.:

91-80-40836609/ 41506699/ 41126126/ 40836600/ 40836666

Fax No.:

91-80-40836613

E-Mail :

kedarnath21jadhav@gmail.com

jeethu@vardhamanhealth.com

vkv_sarma_sama@hotmail.com

Website :

http://www.vardhmanhealth.com

Area :

16000 Sq. Ft

Location :

Rented

 

 

Corporate Office :

#25 , Chanchal Smruthi Building Basement, Unit:18, Katrak Road, Dadar East, G.D Ambekar Marg, Wadala West, Mumbai – 400031, Maharashtra, India

Tel. No.:

91-22-43441234 / 43441216 / 43441217

Fax No.:

91-22-43441214

E-Mail :

kalpesh@vardhmanhealth.com

 

 

Branch Office :

Located at:

 

·         Hyderabad

·         Pune

·         Mumbai

·         Delhi

·         Ahmedabad

·         Chennai

·         Cochin

·         Kolkata

 

 

 

 

DIRECTORS

 

As on 27.09.2013

 

Name :

Mr. Jayantilal Bhoormal Chowhan

Designation :

Managing Director

Address :

No. 19, S.B. Road, Soukhya Residency, 3rd Floor, V.V. Puram, Bangalore – 560 004, Karnataka, India

Date of Birth/Age :

12.10.1954

Date of Appointment :

23.06.1998

DIN No.:

01737124

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110KA1997PTC022000

VARDHMAN HEALTH SPECIALITIES PRIVATE LIMITED

Managing director

23/06/1998

23/06/1998

-

Active

NO

2

U24232TN2001PTC061071

ALLIANCE BIO PHARMA AND GENETICS PRIVATE LIMITED

Director

29/06/2001

29/06/2001

21/03/2008

Active

NO

 

 

Name :

Chandra Jayantilal Chowhan

Designation :

Director

Address :

No. 9, S.B. Road, Flat A3, Soukhya Apartment,  V.V. Puram, Basavanagudi, Bangalore - 560 004, Karnataka, India

Date of Birth/Age :

22.11.1958

Date of Appointment :

01.08.2008

DIN No.:

00331607

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH2002PTC137439

VARDHMAN BIO PHARMA AND GENETICS PRIVATE LIMITED

Director

23/10/2002

23/10/2002

-

Amalgamated

NO

2

U24239MH2007PTC166700

NOVOGENE LIFE SCIENCES PRIVATE LIMITED

Director

04/01/2007

04/01/2007

-

Active

NO

3

U85110KA1997PTC022000

VARDHMAN HEALTH SPECIALITIES PRIVATE LIMITED

Director

01/08/2008

01/08/2008

-

Active

NO

 

 

Name :

Mr. Naresh Jayantilal Chowhan

Designation :

Director

Address :

No. 19, S.B. Road, Soukhya Apartments, Flat A3, Basavanagudi, Bangalore – 560 004, Karnataka, India

Date of Birth/Age :

07.08.1962

Date of Appointment :

21.03.1997

DIN No.:

01737116

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110KA1997PTC022000

VARDHMAN HEALTH SPECIALITIES PRIVATE LIMITED

Director

21/03/1997

21/03/1997

-

Active

NO

2

U24239MH2007PTC166700

NOVOGENE LIFE SCIENCES PRIVATE LIMITED

Additional director

15/10/2011

15/10/2011

-

Active

NO

 

 

Name :

Mr. Kalpesh Jayantilal Chowhan

Designation :

Director

Address :

No. 9, S.B Road, Flat A3, Soukhya Apartment,  V.V. Puram, Basavanagudi, Bangalore – 560 004, Karnataka, India

Date of Birth/Age :

16.08.1982

Date of Appointment :

08.11.2004

DIN No.:

01737119

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110KA1997PTC022000

VARDHMAN HEALTH SPECIALITIES PRIVATE LIMITED

Director

08/11/2004

08/11/2004

-

Active

NO

2

U24239MH2007PTC166700

NOVOGENE LIFE SCIENCES PRIVATE LIMITED

Additional director

15/10/2011

15/10/2011

-

Active

NO

 

 

Name :

Ms. Nita Kumari Parmar

Designation :

Director

Address :

64, 1st Floor, Flat No. 104, Brigade Vintage Apartments, Kanakapura Main Road, Basavangudi, Bangalore – 560 004, Karnataka, India

Date of Birth/Age :

26.04.1978

Date of Appointment :

01.08.2008

DIN No.:

02399878

 

 

KEY EXECUTIVES

 

Name :

Mr. Vikram Bhatt

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS

 

As on 27.09.2013

 

Names of Shareholders

 

No. of Shares

Jayantilal B. Chowhan

 

3557250

Chandra J. Chowhan

 

615750

Naresh J. Chowhan

 

433500

Kalpesh J. Chowhan

 

532500

Nita N. Chowhan

 

411000

Total

 

5550000

 

Equity Share Break up (Percentage of Total Equity)

 

As on 27.09.2013

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Distributor of Speciality Drugs.

 

 

Products :

Products Description

ITC Code

Drugs and Medicines

99611730

 

 

Imports :

 

Products :

Specialty Drugs 

Countries :

Germany

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Suppliers :

Astellas Pharmaceuticals India Private Limited

 

 

Customers :

·         Command Hospital

·         Kidwai Memorial Institute of Oncology

 

 

No. of Employees :

180 (Approximately)

 

 

Bankers :

  • State Bank of Mysore, Basavangudi Branch, K.R. Road, Bangalore-560004, Karnataka, India
  • Axis Bank Limited, No. 55/5, 30th Cross, 13th Main, 4th Block, Jayanagar, Bangalore - 560 011, Karnataka, India
  • Citi Bank N.A, UB City, 3rd Floor, Canberra Block, 24, Vittal Mallya Road, Bangalore-560001, Karnataka, India
  • State Bank of Mysore, Bangalore Branch, K.G. Road, Bangalore – 560 009, Karnataka, India

 

 

Facilities :

SECURED LOANS

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

Rupee term loans from banks

0.158

0.373

Term loans from others

1.292

1.822

Short Term Borrowings

 

 

Rupee term loan from banks

324.682

290.079

Total

326.132

292.274

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S.S. Javali and Associates

Chartered Accountants

Address :

No.19, Kaveriappa Layout, Miller Tank Bund Road, Bangalore – 560 052, Karnataka, India

Tel. No.:

91-80-41205857/ 41327773

Fax No.:

91-80-41327773

E-Mail :

subhashjavali@airtelmail.in

PAN No.:

ABBPJ1895J

 

 

Associates :

Novogene Life Science

CIN No.: U24239MH2007PTC166700

 

 

CAPITAL STRUCTURE

 

As on 27.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6000000

Equity Shares

Rs.10/- each

Rs.60.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5550000

Equity Shares

Rs.10/- each

Rs.55.500 Millions

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

55.500

55.500

55.500

(b) Reserves & Surplus

124.200

100.068

61.223

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

179.700

155.568

116.723

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

2.485

6.193

2.594

(b) Deferred tax liabilities (Net)

0.000

0.000

0.382

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

2.485

6.193

2.976

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

325.381

290.949

246.243

(b) Trade payables

68.587

105.265

138.024

(c) Other current liabilities

3.708

4.592

2.090

(d) Short-term provisions

14.484

21.877

21.411

Total Current Liabilities (4)

412.160

422.683

407.768

 

 

 

 

TOTAL

594.345

584.444

527.467

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

14.487

15.552

14.338

(ii) Intangible Assets

2.116

1.282

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.076

0.154

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

16.679

16.988

14.338

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

190.837

206.636

242.228

(c) Trade receivables

290.087

283.823

210.117

(d) Cash and cash equivalents

16.209

11.220

3.926

(e) Short-term loans and advances

80.533

65.777

56.858

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

577.666

567.456

513.129

 

 

 

 

TOTAL

594.345

584.444

527.467

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

 

 

 

Other Income

 

 

 

 

 

TOTAL                                    

1355.926

1524.103

1297.983

 

 

 

 

 

Less

EXPENSES

1315.868

1462.377

1247.323

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX

40.058

61.726

50.660

 

 

 

 

 

Less

TAX                                                                 

15.926

22.883

18.784

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX

24.132

38.843

31.876

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

100.066

61.223

29.347

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

124.198

100.066

61.223

 

 

 

 

 

 

Earnings Per Share (Rs.)

4.35

NA

NA

 

Expected Sales (2013-2014): Rs.1450.000 Millions

 

Above information has been parted by Mr. VIkram Bhatt (Accounts Manager).

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

1.78

2.55

2.46

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

6.74

10.56

9.60

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.22

0.40

0.43

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.82

1.91

2.13

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.40

1.34

1.26

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOANS:

 

Particulars

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

Rupee term loan from others

1.035

3.998

Short Term Borrowings

 

 

Loans repayable on demand

0.699

0.870

Total

1.734

4.868

 

REVIEW OF OPERATIONS:

 

During the year the turnover of the company is decreased by 11% to Rs.1355.900 Millions as compared to Rs.1524.100 Millions of previous year and the Profit before tax is Rs.40.058 Millions compared to Rs.61.726 Millions of the last year. The Management of the company took conscious decision of cutting down supplies to certain customers who were giving low margin and demanding longer credit period. This resulted in lower turnover. The management has enforced strict control on cost of operation and during the year current year management expects to perform better.

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10220644

08/01/2014 *

165,000,000.00

CITIBANK N. A.

UB City, 3rd Floor, Canberra Block, 24 Vittal Mallya Road, Bangalore, Karnataka - 560001, INDIA

B94658044

2

10197741

12/10/2013 *

160,000,000.00

Axis Bank Limited

Corporate Banking Branch, Express Building, Second Floor, No.1, Queen's Road, Bangalore, Karnataka - 560001, India

B91108167

3

10042717

08/12/2009 *

100,000,000.00

CITIBANK N. A.

Trent House, 2nd Floor, G Block, Plot No.C60, Bandra Kurla Complex, Bandra (E), Mumbai, Maharashtra
- 400051, India

A74508698

*Date of modification Charges

 

FIXED ASSETS:

 

·         Plant and Machinery

·         Computer and Peripherals

·         Furniture and Fixtures

·         Vehicles

·         Computer

 

 

 

 

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.32

UK Pound

1

Rs.101.78

Euro

1

Rs.84.68

 

 

INFORMATION DETAILS

 

Information Gathered by :

HTL

 

 

Report Prepared by :

VNT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

43

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.